149 related articles for article (PubMed ID: 38452585)
1. Beyond the genome: MALAT1's role in advancing urologic cancer care.
Imran M; Abida ; Eltaib L; Siddique MI; Kamal M; Asdaq SMB; Singla N; Al-Hajeili M; Alhakami FA; AlQarni AF; Abdulkhaliq AA; Rabaan AA
Pathol Res Pract; 2024 Apr; 256():155226. PubMed ID: 38452585
[TBL] [Abstract][Full Text] [Related]
2. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma.
Xiao H; Tang K; Liu P; Chen K; Hu J; Zeng J; Xiao W; Yu G; Yao W; Zhou H; Li H; Pan Y; Li A; Ye Z; Wang J; Xu H; Huang Q
Oncotarget; 2015 Nov; 6(35):38005-15. PubMed ID: 26461224
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
5. ARID3A and ARID3B exert direct regulatory control over the long non-coding RNAs (lncRNAs) MALAT1 and NORAD within the context of non-small cell lung cancer (NSCLC).
Nasuh S; Balci SO; Bozgeyik I; Ikeda MA; Tekayev M; Saadat KASM
Pathol Res Pract; 2023 Dec; 252():154948. PubMed ID: 37977034
[TBL] [Abstract][Full Text] [Related]
6. Bridging autoimmunity and epigenetics: The influence of lncRNA MALAT1.
Mohan S; Hakami MA; Dailah HG; Khalid A; Najmi A; Zoghebi K; Halawi MA
Pathol Res Pract; 2024 Feb; 254():155041. PubMed ID: 38199135
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Characterization of Common and Cancer-Specific Differently Expressed lncRNAs in Urologic Cancers.
Yan YJ; Zhang L; Zhou JJ; Chen ZJ; Liao YX; Zeng JM; Shen H
Comput Math Methods Med; 2021; 2021():5515218. PubMed ID: 34335862
[TBL] [Abstract][Full Text] [Related]
8. New Insights into Long Non-Coding RNA
Sun Y; Ma L
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781877
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MALAT1 facilitates lung metastasis of osteosarcomas through miR-202 sponging.
Zhang J; Piao CD; Ding J; Li ZW
Sci Rep; 2020 Jul; 10(1):12757. PubMed ID: 32728178
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer.
Goyal B; Yadav SRM; Awasthee N; Gupta S; Kunnumakkara AB; Gupta SC
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188502. PubMed ID: 33428963
[TBL] [Abstract][Full Text] [Related]
11. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.
Jen J; Tang YA; Lu YH; Lin CC; Lai WW; Wang YC
Mol Cancer; 2017 Jun; 16(1):104. PubMed ID: 28615056
[TBL] [Abstract][Full Text] [Related]
12. Expression Analysis of Long Noncoding RNA-MALAT1 and Interleukin-6 in Inflammatory Bowel Disease Patients.
Nemati Bajestan M; Piroozkhah M; Chaleshi V; Ghiasi NE; Jamshidi N; Mirfakhraie R; Balaii H; Shahrokh S; Asadzadeh Aghdaei H; Salehi Z; Nazemalhosseini Mojarad E
Iran J Allergy Asthma Immunol; 2023 Oct; 22(5):482-494. PubMed ID: 38085149
[TBL] [Abstract][Full Text] [Related]
13. LncRNA polymorphisms and urologic cancer risk.
Abdi E; Latifi-Navid S
Environ Mol Mutagen; 2022 Apr; 63(4):190-203. PubMed ID: 35178782
[TBL] [Abstract][Full Text] [Related]
14. Malat1 as an evolutionarily conserved lncRNA, plays a positive role in regulating proliferation and maintaining undifferentiated status of early-stage hematopoietic cells.
Ma XY; Wang JH; Wang JL; Ma CX; Wang XC; Liu FS
BMC Genomics; 2015 Sep; 16(1):676. PubMed ID: 26335021
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
Hu D; Zhang B; Yu M; Shi W; Zhang L
Mol Med Rep; 2020 Aug; 22(2):620-632. PubMed ID: 32468035
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 (MALAT1) interacts with estrogen receptor and predicted poor survival in breast cancer.
Huang NS; Chi YY; Xue JY; Liu MY; Huang S; Mo M; Zhou SL; Wu J
Oncotarget; 2016 Jun; 7(25):37957-37965. PubMed ID: 27191888
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer.
Zheng L; Zhang Y; Fu Y; Gong H; Guo J; Wu K; Jia Q; Ding X
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30683807
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
19. The role of a ceRNA regulatory network based on lncRNA MALAT1 site in cancer progression.
Su K; Wang N; Shao Q; Liu H; Zhao B; Ma S
Biomed Pharmacother; 2021 May; 137():111389. PubMed ID: 33601150
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA MALAT1 promotes oral squamous cell carcinoma development via microRNA-125b/STAT3 axis.
Chang SM; Hu WW
J Cell Physiol; 2018 Apr; 233(4):3384-3396. PubMed ID: 28926115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]